Tab 1 General characteristics and clinical indexes of control group and LN group
Index | Control group (n=68) | LN group (n=40) | P value |
---|
Age/year | 38.6±13.1 | 42.6±11.3 | 0.078 |
Sex/n (%) | | | 0.057 |
Male | 17 (25.0) | 4 (10.0) | |
Female | 51 (75.0) | 36 (90.0) | |
WBC/(×109·L-1) | 5.7±1.2 | 6.8±2.1 | 0.000 |
RBC/(×1012·L-1) | 4.4±0.6 | 4.1±0.8 | 0.017 |
Hemoglobin/(g·L-1) | 138.8±13.2 | 111.6±18.1 | 0.000 |
Platelet/(×109·L-1) | 217.8±37.7 | 179.5±43.0 | 0.000 |
Albumin/(g·L-1) | 45.7±2.8 | 35.7±4.2 | 0.000 |
Serum creatinine/(μmol·L-1) | 57.9 (54.5, 62.2) | 78.5 (67.6, 100.0) | 0.000 |
h-CRP/(mg·L-1) | 0.3 (0.2, 0.4) | 1.0 (0.3, 2.4) | 0.048 |
24h-UTP/mg | - | 1 580.0 (357.4, 7 214.0) | - |
C3/(g·L-1) | - | 0.7±0.2 | - |
C4/(g·L-1) | - | 0.2±0.1 | - |
Anti-dsDNA | - | 102.0 (39.1, 270.3) | - |
ANA (+)/n (%) | - | 30 (75.0) | - |
Anti-Sm (+)/n (%) | - | 23 (57.5) | - |
Anti-SSA-Ro52 (+)/n (%) | - | 17 (42.5) | - |
Anti-SSA-Ro60 (+)/n (%) | - | 19 (47.5) | - |
ANuA (+)/n (%) | - | 18 (45.0) | - |
Anti-U1RNP (+)/n (%) | - | 11 (27.5) | - |